Christoph Wyen

University of Cologne — Germany

Medicine · Health Sciences

33h-index4.9kcitations137works13.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(55), Lymphoma Diagnosis and Treatment(39), Viral-associated cancers and disorders(39), HIV/AIDS Research and Interventions(37), HIV Research and Treatment(36)

Publications131 total

Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany
Infection·2025Open Access
Effectiveness of switching to doravirine‐based antiretroviral therapy: A real‐world study in Germany
HIV Medicine·2025· 3 citedOpen Access
The effect of antibiotic therapy on clinical outcome in patients hospitalized with moderate COVID-19 disease: a prospective multi-center cohort study
Infection·2025Open Access
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study
The Lancet Infectious Diseases·2025· 16 citedOpen Access
P-1934. Differences between the Reporting of Post-COVID-19 Symptoms and the Associated Health-Related Quality of Life during and after COVID-19 Infection - results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network
Open Forum Infectious Diseases·2025Open Access
Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study
HemaSphere·2024· 3 citedOpen Access
Discrimination of the Veterans Aging Cohort Study Index 2.0 for Predicting Cause-specific Mortality Among Persons With HIV in Europe and North America
Open Forum Infectious Diseases·2024· 2 citedOpen Access
Long-Term Treatment Success with Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF)
2024· 1 citedOpen Access
Survival after cryptococcosis in Germany: A retrospective multicenter cohort study of patients diagnosed between 2004 and 2021
International Journal of Medical Microbiology·2024· 6 citedOpen Access
Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide–Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196
JAIDS Journal of Acquired Immune Deficiency Syndromes·2024· 7 citedOpen Access
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies
The Lancet HIV·2024· 125 citedOpen Access
Dynamics and durability of HIV-1 neutralization are determined by viral replication
Nature Medicine·2023· 13 citedOpen Access
Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathways
Health Care Management Science·2023· 16 citedOpen Access
Contribution of alcohol use in <scp>HIV</scp>/hepatitis C virus co‐infection to all‐cause and cause‐specific mortality: A collaboration of cohort studies
Journal of Viral Hepatitis·2023· 3 citedOpen Access
Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort
Infection·2023· 9 citedOpen Access
Immune response to <scp>mRNA</scp>‐based <scp>COVID</scp>‐19 booster vaccination in people living with <scp>HIV</scp>
HIV Medicine·2023· 8 citedOpen Access
OP 5.5 – 00083 Impairment of HIV proviral reactivation by interfering with essential metabolic pathways in effector memory CD4+ T cells
Journal of Virus Eradication·2022Open Access
COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity
Biomedicines·2022· 7 citedOpen Access
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
Infection·2022· 25 citedOpen Access
Clinical characteristics of monkeypox virus infections among men with and without <scp>HIV</scp>: A large outbreak cohort in Germany
HIV Medicine·2022· 106 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Gerd Fätkenheuer(22), Marcus Hentrich(11), Stefan Eßer(10), Jürgen K. Rockstroh(10), Clara Lehmann(9), Christian Hoffmann(9), Daniel Gillor(8), Christian Hoffmann(8), Johannes R. Bogner(8), Björn‐Erik Ole Jensen(8), Norbert H. Brockmeyer(7), Markus Müller(7), Albrecht Stoehr(7), Stefan Scholten(6), Jörg Janne Vehreschild(6), Heribert Knechten(6), Jan van Lunzen(6), David M. Burger(6), José Moltó(6), Jan Thoden(6)